![Amato Giaccia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amato Giaccia
Fondateur chez Arresto BioSciences, Inc.
Fortune : 150 492 $ au 31/12/2023
Postes actifs de Amato Giaccia
Sociétés | Poste | Début | Fin |
---|---|---|---|
Arresto BioSciences, Inc.
![]() Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Fondateur | 14/08/2009 | - |
Stanford Cancer Institute | Corporate Officer/Principal | - | - |
Stanford University School of Medicine | Corporate Officer/Principal | - | - |
AKSO Biopharmaceutical, Inc. | Président | - | - |
Fondateur | - | - |
Historique de carrière de Amato Giaccia
Anciens postes connus de Amato Giaccia
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARAVIVE, INC. | Directeur/Membre du Conseil | 12/10/2018 | 17/01/2024 |
Independent Dir/Board Member | 12/10/2018 | 17/01/2024 | |
Aravive Biologics, Inc.
![]() Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Directeur/Membre du Conseil | 01/08/2010 | 12/10/2018 |
Directeur Technique/Scientifique/R&D | 01/01/2017 | 12/10/2018 | |
Fondateur | 01/08/2010 | 12/10/2018 | |
Oxford Institute for Energy Studies
![]() Oxford Institute for Energy Studies Miscellaneous Commercial ServicesCommercial Services Oxford Institute for Energy Studies operates as an energy research institute. Its three main programs include oil, natural gas, and electricity. It publishes analysis of topical global energy issues across production, consumption, markets, policy and regulation. The company is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2019 | - |
Versartis, Inc.
![]() Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 12/10/2018 | - |
Proacta, Inc.
![]() Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Fondateur | 01/01/2001 | - |
Formation de Amato Giaccia
University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Royaume-Uni | 2 |
Opérationnelle
Founder | 4 |
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ARAVIVE, INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Proacta, Inc.
![]() Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Oxford Institute for Energy Studies
![]() Oxford Institute for Energy Studies Miscellaneous Commercial ServicesCommercial Services Oxford Institute for Energy Studies operates as an energy research institute. Its three main programs include oil, natural gas, and electricity. It publishes analysis of topical global energy issues across production, consumption, markets, policy and regulation. The company is headquartered in Oxford, the United Kingdom. | Commercial Services |
Arresto BioSciences, Inc.
![]() Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Commercial Services |
Versartis, Inc.
![]() Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Stanford Cancer Institute | |
Aravive Biologics, Inc.
![]() Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
AKSO Biopharmaceutical, Inc. |
- Bourse
- Insiders
- Amato Giaccia
- Expérience